Experimental Treatment Earns Breakthrough Therapy Designation for TK2 Deficiency, a Form of Mitochondrial Disease
argzombies / Pixabay

Experimental Treatment Earns Breakthrough Therapy Designation for TK2 Deficiency, a Form of Mitochondrial Disease

According to a story from BioSpace, the biopharmaceutical company Modis Therapeutics recently announced that the US Food and Drug Administration (FDA) has granted Breakthough Therapy designation for the company's experimental…

Continue Reading Experimental Treatment Earns Breakthrough Therapy Designation for TK2 Deficiency, a Form of Mitochondrial Disease
67 Year Old Non-Hodgkin’s Lymphoma Patient Given Second Chance at Life After Experimental Cell Therapy
source: pixabay.com

67 Year Old Non-Hodgkin’s Lymphoma Patient Given Second Chance at Life After Experimental Cell Therapy

  A grandmother of four in Maryland has recently become the first cancer patient to complete the experimental CAR-T cell procedure at Georgetown University Hospital. Daisy Diggs 67, who was…

Continue Reading 67 Year Old Non-Hodgkin’s Lymphoma Patient Given Second Chance at Life After Experimental Cell Therapy

Experimental Treatment for Macular Telangiectasia Type 2 Earns Fast Track Designation

According to a story from prnewswire.com, the biopharmaceutical company Neurotech Pharmaceuticals recently announced that the company had earned Fast Track designation from the US Food and Drug Administration (FDA). This…

Continue Reading Experimental Treatment for Macular Telangiectasia Type 2 Earns Fast Track Designation
Choroideremia Can Lead to Blindness – But Gene Therapy Might Be Able to Halt It
Source: Pixabay

Choroideremia Can Lead to Blindness – But Gene Therapy Might Be Able to Halt It

An article recently published by the Guardian shared the stories of three families affected by recent breakthroughs in gene therapy treatments. What is Gene Therapy? Gene therapy is an increasingly…

Continue Reading Choroideremia Can Lead to Blindness – But Gene Therapy Might Be Able to Halt It
New Collaborative Effort Will Test a Potential Treatment for Sanfilippo Syndrome
Nappiness / Pixabay

New Collaborative Effort Will Test a Potential Treatment for Sanfilippo Syndrome

According to a story from Market Screener the biotechnology company Bioblast Pharma has announced a new partnership with Team Sanfilippo a nonprofit foundation which is committed to medical research related…

Continue Reading New Collaborative Effort Will Test a Potential Treatment for Sanfilippo Syndrome

FDA Approves Venetoclax Combination For Newly Diagnosed AML in Adults 75 Years or Older

The Food and Drug Administration (FDA) recently announced its approval of Venetoclax (Venclexta)  in combination with either decitabine or azacitidine (hypomethylating agents) or cytarabine (an antimetabolite) to treat adults 75 years…

Continue Reading FDA Approves Venetoclax Combination For Newly Diagnosed AML in Adults 75 Years or Older

Phase 3 Study in Europe Shows Continued Positive Results for Potential New Cystic Fibrosis Treatment

Cystic Fibrosis Cystic fibrosis (CF) is a rare disease caused by the lack (or malfunctioning) of the cystic fibrosis transmembrane conductance regulator (CTFR) protein. This occurs when children inherit a mutated…

Continue Reading Phase 3 Study in Europe Shows Continued Positive Results for Potential New Cystic Fibrosis Treatment

University of Louisville’s Research Team Discovers Molecule That Protects Against Development of Cancer Cells

The University of Louisville’s publication UL News recently reported a finding by its research team regarding an immune checkpoint molecule.  The molecule had been developed for cancer immunotherapy but when…

Continue Reading University of Louisville’s Research Team Discovers Molecule That Protects Against Development of Cancer Cells
Online Gaming Allowed Duchenne Muscular Dystrophy Patient to Transcend Physical Limits
allinonemovie / Pixabay

Online Gaming Allowed Duchenne Muscular Dystrophy Patient to Transcend Physical Limits

According to a story from BBC, Mats Steen passed away at 25 years old due to complications from his Duchenne muscular dystrophy. Upon his death, parents Robert and Trude grieved…

Continue Reading Online Gaming Allowed Duchenne Muscular Dystrophy Patient to Transcend Physical Limits

Upcoming FREE MDS Event in Florida!

Our partner, The MDS Foundation is sponsoring another free MDS Patient & Family/Caregiver Forum. This forum will take place in Jacksonville, Florida When: Saturday, March 30th, 2019 Where: Mayo Clinic Cancer…

Continue Reading Upcoming FREE MDS Event in Florida!
Experimental Cancer Drug Displays Potential in a Number of Rare Cancers
MALCOLUMBUS / Pixabay

Experimental Cancer Drug Displays Potential in a Number of Rare Cancers

According to a story from EurekAlert!, a new type of cancer drug that is being described as a "Trojan horse" that infiltrates cancer tumors is showing potential in several types…

Continue Reading Experimental Cancer Drug Displays Potential in a Number of Rare Cancers

Residential Care for Prader-Willi Syndrome? This Celebrity is Considering It

According to a story from metro.co.uk, celebrity Katie Price, an English television personality, author, singer, and designer is reportedly considering part time residential care for her son Harvey. Harvey has…

Continue Reading Residential Care for Prader-Willi Syndrome? This Celebrity is Considering It
International Phase 2 Clinical Trial Initiated for New Potential Hypoparathyroidism Therapy
Source: Pixabay

International Phase 2 Clinical Trial Initiated for New Potential Hypoparathyroidism Therapy

Hypoparathyroidism Hypoparathyroidism (HP) is caused by low levels of the parathyroid hormone (PTH). Most people develop this disease after thyroid surgery as a result of accidental damage/removal of the parathyroid…

Continue Reading International Phase 2 Clinical Trial Initiated for New Potential Hypoparathyroidism Therapy